One thing keeps pulling attention back how steady Thermo Fisher $TMO  moves through shifts in science spending. Funding dips? The size of operations cushions each bump. Revenue comes in, again and again, without fanfare. Not every big player shouts about wins; some just deliver them. Over years, that quiet rhythm adds up more than expected.